FDA Warning Letter — Octapharma AB
The FDA took a Warning Letter action against Octapharma AB on Apr 15, 2011 (Stockholm, Sweden). The action was issued by CBER and concerns biologics products. This facility has 5 or more recent FDA inspections on record.
Action details
- Facility
- Octapharma AB
- Date
- Apr 15, 2011
- Fiscal Year
- 2011
- Product Type
- Biologics
- Center
- CBER
- Location
- Stockholm (Sweden)